Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Free Report) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 27,100 shares, a growth of 298.5% from the November 30th total of 6,800 shares. Approximately 4.9% of the company’s stock are sold short. Based on an average trading volume of 617,400 shares, the days-to-cover ratio is currently 0.0 days.
Bluejay Diagnostics Price Performance
Shares of Bluejay Diagnostics stock traded down $0.13 during trading on Friday, hitting $3.62. 86,235 shares of the stock were exchanged, compared to its average volume of 171,963. The firm’s 50-day moving average price is $4.33 and its 200 day moving average price is $25.49. The stock has a market cap of $2.00 million, a price-to-earnings ratio of 0.00 and a beta of 0.70. Bluejay Diagnostics has a 12-month low of $3.03 and a 12-month high of $532.00.
Institutional Trading of Bluejay Diagnostics
A hedge fund recently raised its stake in Bluejay Diagnostics stock. Anson Funds Management LP lifted its stake in shares of Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Free Report) by 359.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 319,280 shares of the company’s stock after buying an additional 249,770 shares during the quarter. Anson Funds Management LP owned about 1.93% of Bluejay Diagnostics worth $41,000 at the end of the most recent reporting period. 18.47% of the stock is owned by institutional investors and hedge funds.
About Bluejay Diagnostics
Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.
Featured Articles
- Five stocks we like better than Bluejay Diagnostics
- Airline Stocks – Top Airline Stocks to Buy Now
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- How AI Implementation Could Help MongoDB Roar Back in 2025
- How to Buy Cheap Stocks Step by Step
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Bluejay Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluejay Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
